Drug Profile
Beclometasone hydrofluoroalkane inhalation - IVAX
Alternative Names: Beclazone; Beclometasone dipropionate hydrofluoroalkane inhalation - Baker Norton; Beclometasone HFA inhalation - Baker Norton; Beclometasone HFA inhalation - IVAX; Beclometasone hydrofluoroalkane inhalation - Baker Norton; Beclomethasone dipropionate hydrofluoroalkane inhalation - Baker Norton; Beclomethasone HFA inhalation - Baker Norton; Beclomethasone HFA inhalation - IVAX; Beclomethasone hydrofluoroalkane inhalation - Baker Norton; Beclomethasone hydrofluoroalkane inhalation - IVAXLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator IVAX Laboratories
- Developer IVAX Laboratories; Taisho Pharmaceutical
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Asthma
Most Recent Events
- 02 Jul 2001 Baker Norton is now called IVAX Laboratories
- 31 Dec 2000 Registered for Asthma in Germany (Inhalation)
- 31 Dec 2000 Registered for Asthma in Spain (Inhalation)